Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve ...

Few celebrity chefs are as instantly recognisable as Gordon Ramsay, whose razor-sharp tongue and unforgiving food standards ...

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

Vanessa Williams is opening up about life after 60. The actress and singer, 62, fresh off a West End production of "The Devil ...

Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said ...

Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

Oprah Winfrey, 71, revealed the reason she returned to taking GLP-1 drugs after taking a year-long break while voicing strong ...

The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...